EP3569711
LIGAND-MODIFIED DOUBLE-STRANDED NUCLEIC ACIDS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.12.2015EP published:
3.2.2021EP application number:
19180844.3
EPO information:
European Patent Register
Max expiry date:
14.12.2035
Title:
LIGAND-MODIFIED DOUBLE-STRANDED NUCLEIC ACIDS
Timeline
Today
15.12.2015EP application
3.2.2021EP Publication
Owner
Name:
Dicerna Pharmaceuticals, Inc.Address:
33, Hayden Avenue, Lexington, MA 02421, US
Inventor
Name:
BROWN, Bob, DaleAddress:
Littleton, MA 01460, US
Name:
WANG, WeiminAddress:
Lexington, MA 02421, US
Priority
Number:
201462092241 PDate:
15.12.2014Country:
US
Number:
201462092238 PDate:
15.12.2014Country:
US
Number:
201562187856 PDate:
2.7.2015Country:
US
Number:
201562187848 PDate:
2.7.2015Country:
US
Classification
Categories:
C12N 15/11, C12N 15/113, A61K 47/54, C07H 21/04, C07H 1/00, C07H 99/00